pital

Welcome to the 30th Annual Enterprise Awards.

Our region's most prestigious celebration of achievement, innovation, and success for leaders in life sciences and technology will be taking place in May 2023.

View the 2022 Enterprise Awards on our YouTube Channel.

NAVIGATION

CELEBRATE OUR INNOVATORS!

Save the Date: May 2023

The 2023 Enterprise Awards will take place in May 2023 with a live awards program where all of our Finalists will be featured and Winners announced. The ceremony will be followed by a celebration of our finalists and honorees.

Dress code is “smart casual” (no suit, no ties, no fancy dresses).

Sponsors

Title Sponsor

Fairmount

Judging Partner

kpmg-pactcapcon-website

AWARD SPONSORS

EVENT SPONSORS

Judges

LEAD JUDGE

Rick Riegel
Chairman

ActiGraph and Deerfield

 

Technology Judging Panel Oversight

Andrew Cherry
Partner

KPMG

Life Sciences & Healthcare Judging Panel Oversight

Jennifer Strong
Partner
KPMG

Tom Koncsics
Partner
KPMG

Award Criteria

To View the Enterprise Awards Applications, please click on each award heading below.

Nomination Form »

The Deadline for Nominations Is Friday, November 18th

HEALTHCARE INNOVATOR

Sponsor: Independence Blue Cross

Criteria:

  • The nominee can be a company, researcher, or investor providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • The Nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.
  • The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth or adoption.
  • The Nominee can be in any sector (technology, life sciences, investment, healthcare delivery., etc.), but must be serving the healthcare industry in Greater Philadelphia.

INVESTMENT DEAL

Sponsor: Baker Tilly

Criteria:

  • Deal must have been fully executed between November 1, 2021, and October 31, 2022.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
  • Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

  • Realized returns for the investors and management.
  • EBITDA margin and revenue growth.
  • Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
  • Company performance prior to transaction.
  • How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.

LIFE SCIENCES & HEALTHCARE STARTUP

Sponsors: Blank Rome and Ben Franklin Technology Partners

Criteria:

  • Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point between January 1, 2019, and December 31, 2022.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Product innovation including unmet market need and how that is uniquely addressed by your product/service.
  • The management team and its ability and record of achieving success.
  • Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
  • Describe the R&D investment strategy.
  • What did the company do to overcome challenges in financing, development, or commercialization?

LIFE SCIENCES & HEALTHCARE EMERGING

Sponsors: SAP and RSM

Criteria:

  • Company must have been in operation beginning on January 1, 2019.  The Company should have no more than 8 years of operating results since its founding.
  • Must have sales, grants, or licensing fees.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Describe product or service, including proprietary applications or other competitive advantage.
  • The impact on the clinical problem this product or innovation is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
  • Company milestones including strategic decisions made by the management team that led to growth in revenues and/or earnings, corporate collaborations, or license deals (e.g. ability to raise capital, strategy to achieve breakeven, ability to realize high gross margins, etc.).

LIFE SCIENCES & HEALTHCARE COMPANY OF THE YEAR

Criteria:

  • Company must have at least four years of operating results in industry segments such as specialty pharmaceuticals, biotechnology, medical devices, instrumentation, therapeutics, diagnostics, health tech, etc.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Company should demonstrate the impact of a proprietary product to the patient and/or clinician or research and development of an innovative product and its potential impact on the market.
  • Company should demonstrate its ability to raise capital; achieve success in its development strategy and clinical pathway; commercialize and generate revenue.
  • Describe any significant events, e.g. product discovery, drug registration, commercial launch, an exit, an increase in sales, etc. that occurred in 2022.
  • What did the company do to overcome challenges in financing, development, or commercialization?

LIFE SCIENCES & HEALTHCARE CEO

Sponsors: EY and Morgan Lewis

Criteria:

  • CEO must be in his/her position for at least two years.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the Company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talented resources.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community/industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.

TECHNOLOGY CEO

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsor: Cozen O’Connor

Criteria:

  • Individual’s background (CV/Bio required) and the company’s success to date.
  • The CEO must be in his/her position for at least two years.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talented resources.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community and/or industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the technology industry in the region.

TECHNOLOGY COMPANY

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsor:  Comcast Business

Criteria:

  • Company with more than $50 million in revenues projected for the current fiscal year.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Leadership and product and/or service innovation in an industry or market.
  • Significant company milestones including financial accomplishments.
  • The Company’s connection and commitments to the Greater Philadelphia region through community and industry involvement.

TECHNOLOGY STARTUP

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors: Troutman Pepper and Bank of America

Criteria:

  • Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2019, and December 31, 2022.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Product or service innovation including market need or assessment.
  • Potential for significant growth.
  • The management team and its ability and record of achieving success.
  • A demonstration of success such as significant milestones, raising capital, and revenue.

TECHNOLOGY EMERGING

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors: Fox Rothschild and Broadpath

Criteria:

  • Company must have been in operation before January 1, 2019.
  • Revenues must be less than $50 million. *If revenues are projected to exceed $50m in 2022, please complete the Technology Company application.
  • Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

  • Product or service innovation, including proprietary technology or other advantage.
  • Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
  • Strength of management team including ability to raise capital.
  • Demonstration of a sustainable and scalable business model